Indications For Irradiation Of Cellular Blood Products
From Anvita Health Wiki
Contents |
Introduction
- well established risk
- recipeints of allogeneic or autologous bone marrow or stem cell transplants
- patients receiving aggressive chemotherapy &/or radiation therapy for malignancy
- transfusions from blood relatives
- HLA-matched platelet transfusions
- congenital immunodeficiency syndromes
- premature infants
- intrauterine transfusions
- neonatal exchange transfusions
- risk less well established
- recipients of solid organ transplants
- nearly all cases of GVHD are caused by engraftment of lymphocytes from the donor organ rather than from blood products
More General Terms
Additional Terms
References
Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998
